{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:53:33Z","timestamp":1763535213091},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T00:00:00Z","timestamp":1359763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00192-012-2038-y","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T19:08:28Z","timestamp":1359745708000},"page":"1523-1528","source":"Crossref","is-referenced-by-count":23,"title":["Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder"],"prefix":"10.1007","volume":"24","author":[{"given":"G.","family":"Vijaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Derpapas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,2]]},"reference":[{"issue":"2","key":"2038_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncpuro0408","volume":"3","author":"WD Steers","year":"2006","unstructured":"Steers WD, Tuttle JB (2006) Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 3(2):101\u2013110. doi: 10.1038\/ncpuro0408","journal-title":"Nat Clin Pract Urol"},{"issue":"3","key":"2038_CR2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-5347(05)66587-1","volume":"165","author":"YC Chuang","year":"2001","unstructured":"Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N (2001) The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 165(3):975\u2013979","journal-title":"J Urol"},{"key":"2038_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6793-7-9","volume":"7","author":"P Zvara","year":"2007","unstructured":"Zvara P, Vizzard MA (2007) Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol 7:9. doi: 10.1186\/1472-6793-7-9","journal-title":"BMC Physiol"},{"issue":"3","key":"2038_CR4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)65931-9","volume":"166","author":"MC Dupont","year":"2001","unstructured":"Dupont MC, Spitsbergen JM, Kim KB, Tuttle JB, Steers WD (2001) Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166(3):1111\u20131118","journal-title":"J Urol"},{"issue":"5","key":"2038_CR5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","volume":"175","author":"JC Kim","year":"2006","unstructured":"Kim JC, Park EY, Seo SI, Park YH, Hwang TK (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773\u20131776. doi: 10.1016\/s0022-5347(05)00992-4 , discussion 1776","journal-title":"J Urol"},{"issue":"12","key":"2038_CR6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0929-6646(10)60133-7","volume":"109","author":"HT Liu","year":"2010","unstructured":"Liu HT, Chen CY, Kuo HC (2010) Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders. J Formos Med Assoc 109(12):862\u2013878. doi: 10.1016\/s0929-6646(10)60133-7","journal-title":"J Formos Med Assoc"},{"key":"2038_CR7","doi-asserted-by":"crossref","unstructured":"Cho KJ, Kim HS, Koh JS, Kim JC (2012) Changes in urinary nerve growth factor and prostaglandin E(2) in women with overactive bladder after anticholinergics. Int Urogynecol J. doi: 10.1007\/s00192-012-1854-4","DOI":"10.1007\/s00192-012-1854-4"},{"issue":"8","key":"2038_CR8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/nau.21118","volume":"30","author":"HT Liu","year":"2011","unstructured":"Liu HT, Lin H, Kuo HC (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30(8):1525\u20131529. doi: 10.1002\/nau.21118","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"2038_CR9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00192-012-1682-6","volume":"23","author":"MA Banakhar","year":"2012","unstructured":"Banakhar MA, Al-Shaiji TF, Hassouna MM (2012) Pathophysiology of overactive bladder. Int Urogynecol J 23(8):975\u2013982. doi: 10.1007\/s00192-012-1682-6","journal-title":"Int Urogynecol J"},{"issue":"7","key":"2038_CR10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1464-410X.2009.08535.x","volume":"104","author":"S Garnett","year":"2009","unstructured":"Garnett S, Swithinbank L, Ellis-Jones J, Abrams P (2009) The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women. BJU Int 104(7):948\u2013953. doi: 10.1111\/j.1464-410X.2009.08535.x","journal-title":"BJU Int"},{"issue":"11","key":"2038_CR11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00192-012-1781-4","volume":"23","author":"P Diamond","year":"2012","unstructured":"Diamond P, Hassonah S, Alarab M, Lovatsis D, Drutz HP (2012) The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study. Int Urogynecol J 23(11):1577\u20131580. doi: 10.1007\/s00192-012-1781-4","journal-title":"Int Urogynecol J"},{"issue":"5","key":"2038_CR12","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.juro.2010.01.008","volume":"183","author":"R Khasriya","year":"2010","unstructured":"Khasriya R, Khan S, Lunawat R, Bishara S, Bignal J, Malone-Lee M, Ishii H, O\u2019Connor D, Kelsey M, Malone-Lee J (2010) The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria. J Urol 183(5):1843\u20131847. doi: 10.1016\/j.juro.2010.01.008","journal-title":"J Urol"},{"issue":"10","key":"2038_CR13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00192-011-1506-0","volume":"22","author":"CA Walsh","year":"2011","unstructured":"Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH (2011) Prevalence of \u201clow-count\u201d bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study. Int Urogynecol J 22(10):1267\u20131272. doi: 10.1007\/s00192-011-1506-0","journal-title":"Int Urogynecol J"},{"issue":"10","key":"2038_CR14","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/j.1464-410X.2010.09684.x","volume":"107","author":"R Cartwright","year":"2011","unstructured":"Cartwright R, Srikrishna S, Cardozo L, Robinson D (2011) Validity and reliability of the patient\u2019s perception of intensity of urgency scale in overactive bladder. BJU Int 107(10):1612\u20131617. doi: 10.1111\/j.1464-410X.2010.09684.x","journal-title":"BJU Int"},{"issue":"6","key":"2038_CR15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","volume":"49","author":"KS Coyne","year":"2006","unstructured":"Coyne KS, Matza LS, Kopp Z, Abrams P (2006) The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 49(6):1079\u20131086. doi: 10.1016\/j.eururo.2006.01.007","journal-title":"Eur Urol"},{"issue":"3","key":"2038_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","volume":"42","author":"P Tyagi","year":"2010","unstructured":"Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y, Chancellor M (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42(3):629\u2013635. doi: 10.1007\/s11255-009-9647-5","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"2038_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1398-9995.1997.tb01247.x","volume":"52","author":"L Aloe","year":"1997","unstructured":"Aloe L, Bracci-Laudiero L, Bonini S, Manni L (1997) The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 52(9):883\u2013894","journal-title":"Allergy"},{"issue":"1","key":"2038_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","volume":"21","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5\u201326. doi: 10.1007\/s00192-009-0976-9","journal-title":"Int Urogynecol J"},{"issue":"7","key":"2038_CR19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1464-410x.2000.00619.x","volume":"85","author":"KH Moore","year":"2000","unstructured":"Moore KH, Simons A, Mukerjee C, Lynch W (2000) The relative incidence of detrusor instability and bacterial cystitis detected on the urodynamic-test day. BJU Int 85(7):786\u2013792","journal-title":"BJU Int"},{"issue":"3","key":"2038_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/nau.22223","volume":"31","author":"S Salvatore","year":"2012","unstructured":"Salvatore S, Serati M, Origoni M, Candiani M (2012) Is overactive bladder in children and adults the same condition? ICI-RS 2011. Neurourol Urodyn 31(3):349\u2013351. doi: 10.1002\/nau.22223","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"2038_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00192-010-1263-5","volume":"22","author":"E Hessdoerfer","year":"2011","unstructured":"Hessdoerfer E, Jundt K, Peschers U (2011) Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J 22(2):229\u2013232. doi: 10.1007\/s00192-010-1263-5","journal-title":"Int Urogynecol J"},{"issue":"3","key":"2038_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1464-410X.2005.05632.x","volume":"96","author":"MP Fitzgerald","year":"2005","unstructured":"Fitzgerald MP, Ayuste D, Brubaker L (2005) How do urinary diaries of women with an overactive bladder differ from those of asymptomatic controls? BJU Int 96(3):365\u2013367. doi: 10.1111\/j.1464-410X.2005.05632.x","journal-title":"BJU Int"},{"issue":"2","key":"2038_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.10099","volume":"22","author":"GA Digesu","year":"2003","unstructured":"Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 22(2):105\u2013108. doi: 10.1002\/nau.10099","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"2038_CR24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/01443610802097690","volume":"28","author":"PM Latthe","year":"2008","unstructured":"Latthe PM, Toozs-Hobson P, Gray J (2008) Mycoplasma and ureaplasma colonisation in women with lower urinary tract symptoms. J Obstet Gynaecol 28(5):519\u2013521. doi: 10.1080\/01443610802097690","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"2038_CR25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11934-008-0054-8","volume":"9","author":"R Saini","year":"2008","unstructured":"Saini R, Gonzalez RR, Te AE (2008) Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link. Curr Urol Rep 9(4):314\u2013319","journal-title":"Curr Urol Rep"},{"issue":"7","key":"2038_CR26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00192-012-1715-1","volume":"23","author":"SM Hsiao","year":"2012","unstructured":"Hsiao SM, Lin HH, Kuo HC (2012) The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 23(7):935\u2013940. doi: 10.1007\/s00192-012-1715-1","journal-title":"Int Urogynecol J"},{"issue":"6","key":"2038_CR27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","volume":"53","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53(6):1245\u20131253. doi: 10.1016\/j.eururo.2008.02.037","journal-title":"Eur Urol"},{"issue":"1","key":"2038_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1874467210801010068","volume":"1","author":"SC Tauber","year":"2008","unstructured":"Tauber SC, Nau R (2008) Immunomodulatory properties of antibiotics. Curr Mol Pharmacol 1(1):68\u201379","journal-title":"Curr Mol Pharmacol"},{"key":"2038_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-7-13","volume":"7","author":"PE Kerrebroeck Van","year":"2009","unstructured":"Van Kerrebroeck PE, Kelleher CJ, Coyne KS, Kopp Z, Brodsky M, Wang JT (2009) Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health Qual Life Outcomes 7:13. doi: 10.1186\/1477-7525-7-13","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2038_CR30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0022-5347(05)67520-9","volume":"163","author":"JW Warren","year":"2000","unstructured":"Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC (2000) Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol 163(6):1685\u20131688","journal-title":"J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-012-2038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2038-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:51:08Z","timestamp":1558623068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-012-2038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,2]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1007\/s00192-012-2038-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,2]]}}}